Background. Little is known regarding the optimal treatment of ventriculoperitoneal (VP) shunt infections in adults. Our aim was to assess the efficacy of treatment strategies and to identify factors ...
Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...
ATLANTA, GA—The implantation of a Ventura (V-Wave) interatrial shunt failed to improve prognosis or reduce symptoms across a wide range of patients with heart failure (HF), results from a new ...
Captured from: Vardi GM. InterShunt: the EASE-HF results. Presented at: TVT 2023. June 8, 2023. Phoenix, AZ. PHOENIX, AZ—A no-implant interatrial shunt (PAS-C; InterShunt Technologies) delivered ...
Allied Market Research recently published a new report, titled, "Hydrocephalus Market by Cause, Type, Diagnosis & Treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results